Alert detail
LCD L35062: Biomarkers Overview — Novitas
What changed
Novitas final LCD on biomarker coverage criteria for Parts A & B.
Who’s affected: Multi-specialty billing teams · Effective: December 12, 2021
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.